Drug Type Antibody drug conjugate (ADC) |
Synonyms ADCT 211 |
Target |
Action inhibitors, modulators |
Mechanism DNA inhibitors(DNA inhibitors), IL-13Rα2 modulators(Interleukin-13 receptor subunit alpha-2 modulators), DNA alkylating agents |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Glioblastoma | Preclinical | United Kingdom | 17 Apr 2023 | |
| Melanoma | Preclinical | United Kingdom | 17 Apr 2023 |






